Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 170

Similar articles for PubMed (Select 15206713)

1.

Tryptophan catabolism and T cell responses.

Mellor AL, Munn D, Chandler P, Keskin D, Johnson T, Marshall B, Jhaver K, Baban B.

Adv Exp Med Biol. 2003;527:27-35. Review.

PMID:
15206713
2.

Extinguishing maternal immune responses during pregnancy: implications for immunosuppression.

Mellor AL, Munn DH.

Semin Immunol. 2001 Aug;13(4):213-8. Review.

PMID:
11437628
3.
4.

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation.

Meisel R, Zibert A, Laryea M, Göbel U, Däubener W, Dilloo D.

Blood. 2004 Jun 15;103(12):4619-21. Epub 2004 Mar 4.

5.

Inhibition of T cell proliferation by macrophage tryptophan catabolism.

Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL.

J Exp Med. 1999 May 3;189(9):1363-72.

6.

Indoleamine 2,3-dioxygenase-expressing antigen-presenting cells and peripheral T-cell tolerance: another piece to the atopic puzzle?

von Bubnoff D, Hanau D, Wenzel J, Takikawa O, Hall B, Koch S, Bieber T.

J Allergy Clin Immunol. 2003 Nov;112(5):854-60. Review.

PMID:
14610470
7.

IDO expression by dendritic cells: tolerance and tryptophan catabolism.

Mellor AL, Munn DH.

Nat Rev Immunol. 2004 Oct;4(10):762-74. Review.

PMID:
15459668
8.

Tryptophan catabolism prevents maternal T cells from activating lethal anti-fetal immune responses.

Mellor AL, Munn DH.

J Reprod Immunol. 2001 Oct-Nov;52(1-2):5-13. Review.

PMID:
11600174
9.

Tryptophan catabolism and regulation of adaptive immunity.

Mellor AL, Munn DH.

J Immunol. 2003 Jun 15;170(12):5809-13. Review. No abstract available.

10.

Indoleamine 2,3 dioxygenase and regulation of T cell immunity.

Mellor A.

Biochem Biophys Res Commun. 2005 Dec 9;338(1):20-4. Epub 2005 Sep 8. Review.

PMID:
16157293
11.

Molecules in focus: indoleamine 2,3-dioxygenase.

King NJ, Thomas SR.

Int J Biochem Cell Biol. 2007;39(12):2167-72. Epub 2007 Jan 20. Review.

PMID:
17320464
12.

Inhibition of allogeneic T-cell responses by dendritic cells expressing transduced indoleamine 2,3-dioxygenase.

Funeshima N, Fujino M, Kitazawa Y, Hara Y, Hara Y, Hayakawa K, Okuyama T, Kimura H, Li XK.

J Gene Med. 2005 May;7(5):565-75.

PMID:
15543532
13.

Tumor immune escape mediated by indoleamine 2,3-dioxygenase.

Zamanakou M, Germenis AE, Karanikas V.

Immunol Lett. 2007 Aug 15;111(2):69-75. Epub 2007 Jul 2. Review.

PMID:
17644189
14.

Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?

Mellor AL, Munn DH.

Immunol Today. 1999 Oct;20(10):469-73. Review.

PMID:
10500295
15.

Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways.

Le Rond S, Gonzalez A, Gonzalez AS, Carosella ED, Rouas-Freiss N.

Immunology. 2005 Nov;116(3):297-307.

16.

Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy.

Mellor AL, Sivakumar J, Chandler P, Smith K, Molina H, Mao D, Munn DH.

Nat Immunol. 2001 Jan;2(1):64-8.

PMID:
11135580
17.

Implications of IFN-gamma-mediated tryptophan catabolism on solid organ transplantation.

Brandacher G, Margreiter R, Fuchs D.

Curr Drug Metab. 2007 Apr;8(3):273-82. Review.

PMID:
17430115
18.

Indoleamine 2,3-dioxygenase gene transfer prolongs cardiac allograft survival.

Li J, Meinhardt A, Roehrich ME, Golshayan D, Dudler J, Pagnotta M, Trucco M, Vassalli G.

Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3415-23. Epub 2007 Oct 12.

19.

Prevention of allogeneic fetal rejection by tryptophan catabolism.

Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, Brown C, Mellor AL.

Science. 1998 Aug 21;281(5380):1191-3.

20.

CDllc+ cells modulate pulmonary immune responses by production of indoleamine 2,3-dioxygenase.

Swanson KA, Zheng Y, Heidler KM, Mizobuchi T, Wilkes DS.

Am J Respir Cell Mol Biol. 2004 Mar;30(3):311-8. Epub 2003 Sep 4.

PMID:
12959949
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk